Tam Protez Hastalarında Palatal Sağlık: Doku Düzenleyiciler ve Klorheksidin Glukonat Ağız Gargaraları Ne Kadar Süre Kullanılmalıdır?

Amaç: Tam protez kullanımı sonucu damak bölgesinde eritema olan hastaların tedavisinde rutin olarak kullanılan klorheksidin glukonat ağız gargarasının ve doku düzenleyicilerin etkisini retrospektif olarak değerlendirmektir. Yöntemler: Kliniğimize başvuran tam protez kullanan ve palatal bölgesinde eritem bulunan hastaların klinik tedavisi süresince palatinal orta hattından alınan fotoğraflar incelendi ve Butz Jorgensen Indeksine göre değerlendiridi. Hastalar 3 gruba ayrıldı (n=8). Birinci gruba doku düzenleyici, ikinci gruba sadece % 0,2’lik klorheksidin glukonat ağız gargarası verildi üçüncü gruba her iki yöntem birlikte uygulandı. Tüm gruplar için değerlendirme süresi iki hafta olarak belirlendi. Hastaların palatal orta hat bölgesinden başlangıç, tedaviden 1. hafta ve 2. hafta sonrasında ağız içi fotoğraflar çekildi. Niteliksel verilerin karşılaştırılmasında Ki-Kare testi, parametrelerin grup içi karşılaştırmalarında ise Wilcoxon işaret testi kullanıldı. Anlamlılık p<0,05 düzeyinde değerlendirildi. Bulgular: Başlangıçta tüm grupların enflamasyon seviyeleri arasında istatistiksel olarak anlamlı bir farklılık bulunmadı. Tüm enflamasyon seviyeleri ciddi olarak skorlandı (p>0,05).Doku düzenleyici ve %0,2’lik klorheksidin glukonat ağız gargarasının birlikte kullanımının palatal enflamasyonun azalmasında etkili olduğu görüldü. Sonuç: Tam protez kullanımı sonucu meydana gelen palatal enflamasyon tedavisinde 2 haftalık doku düzenleyici ve %0,2’lik klorheksidin glukonat ağız gargarasının kullanımı etkilidir.

Palatal Health of Those Wearing Complete Dentures: For How Long Must a Tissue Conditioner and Chlorhexidine Gluconate Mouthrinse be Used?

Objective: Palatal inflammation is usually observed in poorly cleaned dentures. The aim of this study was to retrospectively evaluate the time for which a chlorhexidine gluconate mouthrinse (CGM) and tissue conditioner (TC), which are routinely used in daily clinical practice, should be used on palatal erythema patients wearing complete dentures. Methods: Intraoral pictures taken during the clinical treatment of palatal erythemic patients were evaluated using the Budtz-Jorgensen index. Twenty-four patients wearing complete dentures who had palatal erythema were divided into three groups (n=8): Group 1 patients applied the TC only,  group 2 patients, used a 0.2% CGM only, and group 3 patients used the 0.2% CGM and denture relines with the TC. The treatment duration in all groups was 14 days. Intraoral pictures were taken from the palatal area at the baseline and at 1 and 2 weeks after treatment and were evaluated using the Budtz-Jorgensen index. The chi-square test and Wilcoxon signed-Ranks test were used to compare data (p<0.05). Results: There was no statistically significant difference in inflammation levels among all groups at the baseline. All inflammation levels were severe (p>0.05). The group with the combined use of the TC and 0.2% CGM was found to be effective in reducing palatal inflammation. Conclusion: The combined use of the TC and 0.2% CGM for 2 weeks is effective in the treatment of palatal inflammation due to complete dentures.

___

  • 1. Naik AV, Pai RC. A study of factors contributing to denture stomatitis in a North Indian Community. Int J Dent 2011; 2011: 589064. 2. Budtz-Jörgensen E. The significance of Candida albicans in denture stomatitis. Scand J Dent Res, 1974, 82: 151-90. [CrossRef] 3. Arendorf TM, Walker DM. Denture stomatitis: a review. J Oral Rehabil 1987; 14: 217-27. [CrossRef] 4. Kulak-Ozkan Y, Kazazoglu E, Arikan A. Oral hygiene habits, denture cleanliness, presence of yeasts and stomatitis in elderly people. J Oral Rehabil 2002; 29: 300-4. [CrossRef] 5. Kulak Y, Arikan A, Delibalta N. Comparison of three different treatment methods for generalized denture stomatitis. J Prosthet Dent 1994; 72: 283-8. [CrossRef] 6. Koray M, Ak G, Kurklu E, Issever H, Tanyeri H, Kulekci G, et al. Fluconazole and/or hexeditine for management of oral candidiasis associated with denture-induced stomatitis. Oral Dis 2005; 11: 309-13. [CrossRef] 7. Uludamar A, Özyeşil AG, Ozkan YK. Clinical and microbiological efficacy of three different treatment methods in the management of denture stomatitis. Gerodontology 2011; 28: 104-10. [CrossRef] 8. Davenport JC. The oral distribution of candida in denture stomatitis. Br Dent J 1970; 129: 151-6. [CrossRef] 9. Andrucioli MC, de Macedo LD, Panzeri H, Lara EH, Paranhos Hde F. Comparison of two cleansing pastes for the removal of biofilm from dentures and palatal lesions in patients with atrophic chronic candidiasis. Braz Dent J 2004; 15: 220-4. [CrossRef] 10. Pinto TM, Neves AC, Leão MV, Jorge AO. Vinegar as an antimicrobial agent for control of Candida spp. in complete denture wearers. J Appl Oral Sci 2008; 16: 385-90. [CrossRef] 11. Pires FR, Santos EB, Bonan PR, Almeida OP, Lopes MA. Denture stomatitis and salivary Candida in Brazilian edentulous patients. J Oral Rehabil 2002; 29: 1115-9. [CrossRef] 12. Poulopoulos A, Belazi M, Epivatianos A, Velegraki A, Antoniades D. The role of candida in inflammatory papillary hyperplasia of the palate. J Oral Rehabil 2007; 34: 685-92. [CrossRef] 13. Salerno C, Pascale M, Contaldo M, Esposito V, Busciolano M, Millillo L et al. Candida-associated denture stomatitis. Med Oral Patol Oral Cir Bucal 2011; 16: e139-43. [CrossRef] 14. Lal K, Santarpia RP 3rd, Pollock JJ, Renner RP. Assessment of antimicrobial treatment of denture stomatitis using an in vivo replica model system: therapeutic efficacy of an oral rinse. J Prosthet Dent 1992; 67: 72-7. [CrossRef] 15. Kulak Y, Arikan A. Aetiology of denture stomatitis. J Marmara Univ Dent Fac 1993; 1: 307-14. 16. Figueiral MH, Azul A, Pinto E, Fonseca PA, Branco FM, Scully C. Denture-related stomatitis: identification of aetiological and predisposing factors - a large cohort. J Oral Rehabil 2007; 34: 448-55. [CrossRef] 17. Salles AE, Macedo LD, Fernandes RA, Silva-Lovato CH, Paranhos Hde F. Comparative analysis of biofilm levels in complete upper and lower dentures after brushing associated with specific denture paste and neutral soap. Gerodontology 2007; 24: 217-23. [CrossRef] 18. Schou L, Wight C, Cumming C. Oral hygiene habits, denture plaque, presence of yeasts and stomatitis in institutionalised elderly in Lothian, Scotland. Community Dent Oral Epidemiol 1987; 15: 85-9. [CrossRef] 19. Stafford GD, Arendorf T, Huggett R. The effect of overnight drying and water immersion on candidal colonization and properties of complete dentures. J Dent 1986; 14: 52-6. [CrossRef] 20. Emami E, Séguin J, Rompré PH, de Koninck L, de Grandmont P, Barbeau J. The relationship of myceliated colonies on Candida albicans with denture stomatitis: an in vivo/in vitro study. Int J Prosthodont 2007; 20: 514-20. 21. Gornitsky M, Paradisl I, Landaverde G, Malo AM, Velly AM. A clinical and microbiological evaluation of denture cleansers for geriatric patients in long-term care institutions. J Can Dent Assoc 2002; 68: 39-45. 22. Hickey JC, Zarb GA. Boucher’s Prosthodontic treatment for edentulous patients. 2nd ed., The C.V. Mosby Company, St. Louis, Missouri, 1980, Chap 1, p:33-35. 23. Uludamar A, Ozkan YK, Kadir T, Ceyhan I. In vivo efficacy of alkaline peroxide tablets and mouthwashes on Candida albicans in patients with denture stomatitis. J Appl Oral Sci 2010; 18: 291-6. [CrossRef] 24. Nikawa H, Yamamato T, Hamada T, Rahardjo MB, Murata H, Nakanoda S. Antifungal effect zeolite-incorporated tissue conditioner against Candida albicans growth and/or acid production. J Oral Rehabil 1997; 24: 350-7. [CrossRef] 25. Quirynen M, Avontroodt P, Peeters W, Pauwels M, Coucke W, van Steenberghe D. Effect of different chlorhexidine formulations in mouthrinses on de novo plaque formation. J Clin Periodontol 2001; 28: 1127-36. [CrossRef] 26. Pinelli LA, Montandon AA, Corbi SC, Moraes TA. Ricinus communis treatment of denture stomatitis in institutionalized elderly. J Oral Rehabil 2013; 40: 375-80. [CrossRef] 27. Kanathila H, Bhat AM, Krishna PD. The effectiveness of magnesium oxide combined with tissue conditioners in inhibiting the growth of Candida albicans: an in vitro study. Indian J Dent Res 2011; 22: 613. [CrossRef] 28. Thomas CJ, Nutt GM. The in vitro fungividal properties of Visco-gel alone and combined with nystatin and amphotericin B. J Oral Rehabil 1978; 5: 167-72 [CrossRef] 29. Emami E, Kabawat M, Rompre PH, Feine JS. Linking evidence to treatment for denture stomatitis: a meta-analysis of randomized controlled trials. J Dent 2014: 42; 99-106. [CrossRef] 30. Walker DM, Stafford GD, Huggett R, Newcombe RG. The treatment of denture-induced stomatitis. Evaluation of two agents. Br Dent J 1981; 151: 416-9.[CrossRef]
Clinical and Experimental Health Sciences-Cover
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2011
  • Yayıncı: Marmara Üniversitesi